FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2222685252> ?p ?o ?g. }

• W2222685252 endingPage "e0145521" @default.
• W2222685252 startingPage "e0145521" @default.
• W2222685252 abstract "Objective Receptor for advanced glycation end products (AGEs; RAGE) binds to both AGEs and amyloid-beta peptides. RAGE is involved in chronic complications of type 2 diabetes and Alzheimer’s disease. We aimed to investigate the roles of RAGE, AGEs and the Gly82Ser polymorphism of RAGE in mild cognitive impairment (MCI) among type 2 diabetes patients. Methods Of the 167 hospitalized type 2 diabetes patients recruited, 82 satisfied the diagnostic criteria for MCI, and 85 matched control individuals were classified as non-MCI. Demographic data were collected, and the soluble RAGE (sRAGE) concentrations, serum AGE-peptide (AGE-P) levels, RAGE Gly82Ser genotype and neuropsychological test results were examined. Results The MCI group exhibited a decreased sRAGE level (0.87±0.35 vs. 1.05±0.52 ng/ml, p<0.01) and an increased serum AGE-P level (3.54±1.27 vs. 2.71±1.18 U/ml, p<0.01) compared with the control group. Logistic regression analysis indicated that each unit reduction in the sRAGE concentration increased the MCI risk by 54% (OR 0.46[95% CI 0.22–0.96], p = 0.04) and that each unit increase in the AGE-P level increased the MCI risk by 72% in the type 2 diabetes patients (OR 1.72[95% CI 1.31–2.28], p<0.01). The serum sRAGE level was negatively correlated with the score on the trail making test-B (TMT-B) (r = -0.344, p = 0.002), which indicates early cognitive deficits related to diabetes. Moreover, the AGE-P level was positively correlated with multiple cognitive domains (all p<0.05). No significant differences in the neuropsychological test results or serum RAGE concentrations between the different RAGE genotypes or in the RAGE genotype frequencies between the MCI and control groups were identified (all p>0.05). Conclusions The RAGE pathway partially mediates AGE-induced MCI in diabetic patients. The serum AGE-P level may serve as a serum biomarker of MCI in these individuals, and sRAGE represents a predictor and even a potential intervention target of early cognitive decline in type 2 diabetes patients. Trial registration Advanced Glycation End Products Induced Cognitive Impairment in Diabetes: BDNF Signal Meditated Hippocampal Neurogenesis ChiCTR-OCC-15006060" @default.
• W2222685252 created "2016-06-24" @default.
• W2222685252 creator A5024499412 @default.
• W2222685252 creator A5055872212 @default.
• W2222685252 creator A5066562420 @default.
• W2222685252 creator A5072692473 @default.
• W2222685252 creator A5073557868 @default.
• W2222685252 creator A5081704342 @default.
• W2222685252 creator A5086722810 @default.
• W2222685252 date "2016-01-08" @default.
• W2222685252 modified "2023-10-16" @default.
• W2222685252 title "RAGE and AGEs in Mild Cognitive Impairment of Diabetic Patients: A Cross-Sectional Study" @default.
• W2222685252 cites W147553750 @default.
• W2222685252 cites W1561751955 @default.
• W2222685252 cites W1887630777 @default.
• W2222685252 cites W195589071 @default.
• W2222685252 cites W1965302577 @default.
• W2222685252 cites W1966234811 @default.
• W2222685252 cites W1967871511 @default.
• W2222685252 cites W1973795913 @default.
• W2222685252 cites W1986014108 @default.
• W2222685252 cites W1986711635 @default.
• W2222685252 cites W1987611063 @default.
• W2222685252 cites W2003138766 @default.
• W2222685252 cites W2003269588 @default.
• W2222685252 cites W2004449360 @default.
• W2222685252 cites W2007281508 @default.
• W2222685252 cites W2011382030 @default.
• W2222685252 cites W2032440627 @default.
• W2222685252 cites W2038967600 @default.
• W2222685252 cites W2041477088 @default.
• W2222685252 cites W2044437167 @default.
• W2222685252 cites W2046949772 @default.
• W2222685252 cites W2049167261 @default.
• W2222685252 cites W2052150227 @default.
• W2222685252 cites W2052933185 @default.
• W2222685252 cites W2053704338 @default.
• W2222685252 cites W2058067449 @default.
• W2222685252 cites W2066512884 @default.
• W2222685252 cites W2069435653 @default.
• W2222685252 cites W2069959009 @default.
• W2222685252 cites W2079096553 @default.
• W2222685252 cites W2080273024 @default.
• W2222685252 cites W2081080245 @default.
• W2222685252 cites W2084970815 @default.
• W2222685252 cites W2092954980 @default.
• W2222685252 cites W2095820351 @default.
• W2222685252 cites W2096970718 @default.
• W2222685252 cites W2102757269 @default.
• W2222685252 cites W2109334664 @default.
• W2222685252 cites W2115309909 @default.
• W2222685252 cites W2118385532 @default.
• W2222685252 cites W2118856484 @default.
• W2222685252 cites W2120491838 @default.
• W2222685252 cites W2131316309 @default.
• W2222685252 cites W2131565364 @default.
• W2222685252 cites W2134293572 @default.
• W2222685252 cites W2139054731 @default.
• W2222685252 cites W2139563064 @default.
• W2222685252 cites W2142473378 @default.
• W2222685252 cites W2153631628 @default.
• W2222685252 cites W2161024158 @default.
• W2222685252 cites W2161624379 @default.
• W2222685252 cites W2203176997 @default.
• W2222685252 cites W2413697152 @default.
• W2222685252 doi "https://doi.org/10.1371/journal.pone.0145521" @default.
• W2222685252 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4706319" @default.
• W2222685252 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26745632" @default.
• W2222685252 hasPublicationYear "2016" @default.
• W2222685252 type Work @default.
• W2222685252 sameAs 2222685252 @default.
• W2222685252 citedByCount "31" @default.
• W2222685252 countsByYear W22226852522016 @default.
• W2222685252 countsByYear W22226852522017 @default.
• W2222685252 countsByYear W22226852522018 @default.
• W2222685252 countsByYear W22226852522019 @default.
• W2222685252 countsByYear W22226852522020 @default.
• W2222685252 countsByYear W22226852522021 @default.
• W2222685252 countsByYear W22226852522022 @default.
• W2222685252 countsByYear W22226852522023 @default.
• W2222685252 crossrefType "journal-article" @default.
• W2222685252 hasAuthorship W2222685252A5024499412 @default.
• W2222685252 hasAuthorship W2222685252A5055872212 @default.
• W2222685252 hasAuthorship W2222685252A5066562420 @default.
• W2222685252 hasAuthorship W2222685252A5072692473 @default.
• W2222685252 hasAuthorship W2222685252A5073557868 @default.
• W2222685252 hasAuthorship W2222685252A5081704342 @default.
• W2222685252 hasAuthorship W2222685252A5086722810 @default.
• W2222685252 hasBestOaLocation W22226852521 @default.
• W2222685252 hasConcept C126322002 @default.
• W2222685252 hasConcept C134018914 @default.
• W2222685252 hasConcept C147990577 @default.
• W2222685252 hasConcept C151956035 @default.
• W2222685252 hasConcept C15744967 @default.
• W2222685252 hasConcept C169760540 @default.
• W2222685252 hasConcept C2777180221 @default.
• W2222685252 hasConcept C2778857457 @default.
• W2222685252 hasConcept C555293320 @default.

• next